Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

541
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

632
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Congenital Prepapillary Vascular Loops.

Ophthalmology. Retina·2026
Same author

To treat or not to treat: The clue lies in multimodal imaging.

Indian journal of ophthalmology·2026
Same author

Blinded by precision-laser induced macular injury.

Eye (London, England)·2026
Same author

Feathery cataract.

Eye (London, England)·2026
Same author

Penetration with inflation: post traumatic air in AC.

Eye (London, England)·2026
Same author

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026

Video Experimental Relacionado

Updated: Feb 6, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K

Papel protector de la frambuesa en enfermedades inflamatorias: una visión general

Priyanka Arya1, Vikram Sharma1, Priyanka Singh2

  • 1Galgotias College of Pharmacy, Greater Noida, U.P., India.

Iranian journal of basic medical sciences
|February 5, 2026
PubMed
Resumen

Las frambuesas, ricas en polifenoles, exhiben potentes propiedades antiinflamatorias y antioxidantes. Modulan vías de señalización clave, ofreciendo potencial terapéutico para enfermedades inflamatorias como afecciones cardiovasculares, neurodegeneración y cáncer.

Palabras clave:
AlzheimerAterosclerosisCáncerCardiovascularInflamaciónNeuroinflamaciónParkinsonFrambuesa

Más Videos Relacionados

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
09:31

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Published on: November 9, 2018

9.1K
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

Videos de Experimentos Relacionados

Last Updated: Feb 6, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K
Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
09:31

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Published on: November 9, 2018

9.1K
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

Área de la Ciencia:

  • Ciencia de la Nutrición y Bioquímica
  • Biología Molecular e Inmunología
  • Farmacología y Terapéutica

Sus antecedentes:

  • La inflamación es una respuesta inmune fundamental a patógenos, daño celular y toxinas, que puede provocar trastornos inflamatorios agudos y crónicos.
  • Las afecciones inflamatorias abarcan una variedad de enfermedades, incluidas las enfermedades cardiovasculares, la neuroinflamación, la artritis y el cáncer.
  • Las células inmunes y las vías de señalización inflamatoria críticas son activadas por estímulos tanto infecciosos como no infecciosos.

Objetivo del estudio:

  • Revisar los conocimientos mecanísticos sobre los roles protectores de las frambuesas (Rubus idaeus) en el manejo de trastornos relacionados con la inflamación.
  • Destacar el potencial terapéutico de los compuestos bioactivos de la frambuesa contra las enfermedades cardiovasculares, las afecciones neurodegenerativas y el cáncer.

Principales métodos:

  • Revisión de la literatura centrada en estudios que investigan las propiedades antiinflamatorias y antioxidantes de los constituyentes bioactivos de la frambuesa.
  • Análisis de investigaciones que detallan los efectos de los compuestos de la frambuesa en diversas vías de señalización inflamatoria (por ejemplo, MAPKs, NF-κB, PI3K/Akt).
  • Examen de estudios que informan sobre los efectos farmacológicos de las frambuesas, incluidas las actividades cardioprotectoras, hepatoprotectoras y anticancerígenas.

Principales resultados:

  • Las frambuesas son ricas en polifenoles (antocianinas, flavanoles, ácidos fenólicos, urolitina A, ácido elágico) con significativas actividades antiinflamatorias y antioxidantes.
  • Estos compuestos regulan eficazmente múltiples vías de señalización inflamatoria, incluidas MAPKs, NF-κB, PI3K/Akt, AP-1, IL-6, TNF-α, IL-1β, CD40, óxido nítrico (NO), caspasas y la vía JAK-STAT.
  • Los componentes de la frambuesa demuestran amplios beneficios farmacológicos, como propiedades antiinflamatorias, antioxidantes, hepatoprotectoras, cardioprotectoras, gastroprotectoras, contra la obesidad, despigmentantes de la piel y regeneradoras de huesos.

Conclusiones:

  • Las frambuesas poseen un potencial terapéutico significativo para el manejo de trastornos inflamatorios debido a sus ricos compuestos bioactivos.
  • Los mecanismos antiinflamatorios implican la regulación de vías de señalización clave, ofreciendo efectos protectores contra enfermedades cardiovasculares, afecciones neurodegenerativas y cáncer.
  • La investigación adicional sobre las acciones mecanicistas de la frambuesa puede allanar el camino para nuevas estrategias terapéuticas contra las enfermedades relacionadas con la inflamación.